DEF 14A
REGENERON PHARMACEUTICALS, INC.
- Company
- REGENERON PHARMACEUTICALS, INC.
- Filed
- May 1, 2003
- Period of Report
- June 13, 2003
- Accession Number
- 0000950123-03-005127
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →